Cambridge Investment Research Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-960
| Closed | -$236K | – | 3249 |
|
|
2022
Q3 | $236K | Sell |
960
-18
| -2% | -$4.43K | ﹤0.01% | 2573 |
|
|
2022
Q2 | $242K | Buy |
978
+68
| +7% | +$16.8K | ﹤0.01% | 2563 |
|
|
2022
Q1 | $301K | Buy |
910
+66
| +8% | +$21.8K | ﹤0.01% | 2558 |
|
|
2021
Q4 | $303K | Sell |
844
-28
| -3% | -$10.1K | ﹤0.01% | 2518 |
|
|
2021
Q3 | $284K | Sell |
872
-16
| -2% | -$5.21K | ﹤0.01% | 2510 |
|
|
2021
Q2 | $277K | Sell |
888
-335
| -27% | -$104K | ﹤0.01% | 2538 |
|
|
2021
Q1 | $390K | Sell |
1,223
-92
| -7% | -$29.3K | ﹤0.01% | 2085 |
|
|
2020
Q4 | $426K | Sell |
1,315
-13,637
| -91% | -$4.42M | ﹤0.01% | 1882 |
|
|
2020
Q3 | $4.14M | Buy |
14,952
+13,403
| +865% | +$3.71M | 0.03% | 526 |
|
|
2020
Q2 | $374K | Buy |
1,549
+22
| +1% | +$5.31K | ﹤0.01% | 1713 |
|
|
2020
Q1 | $222K | Sell |
1,527
-566
| -27% | -$82.3K | ﹤0.01% | 1868 |
|
|
2019
Q4 | $357K | Buy |
2,093
+129
| +7% | +$22K | ﹤0.01% | 1805 |
|
|
2019
Q3 | $349K | Buy |
1,964
+208
| +12% | +$37K | ﹤0.01% | 1725 |
|
|
2019
Q2 | $457K | Buy |
1,756
+110
| +7% | +$28.6K | ﹤0.01% | 1485 |
|
|
2019
Q1 | $470K | Buy |
1,646
+192
| +13% | +$54.8K | ﹤0.01% | 1520 |
|
|
2018
Q4 | $473K | Sell |
1,454
-8,327
| -85% | -$2.71M | 0.01% | 1357 |
|
|
2018
Q3 | $4.4M | Buy |
9,781
+642
| +7% | +$289K | 0.04% | 411 |
|
|
2018
Q2 | $3.74M | Buy |
9,139
+146
| +2% | +$59.7K | 0.04% | 421 |
|
|
2018
Q1 | $2.62M | Buy |
8,993
+206
| +2% | +$59.9K | 0.03% | 539 |
|
|
2017
Q4 | $1.65M | Sell |
8,787
-289
| -3% | -$54.2K | 0.02% | 654 |
|
|
2017
Q3 | $1.53M | Buy |
+9,076
| New | +$1.53M | 0.02% | 635 |
|